Anpario plc (LON:ANP - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 390.26 ($5.14) and traded as high as GBX 438.49 ($5.78). Anpario shares last traded at GBX 429.27 ($5.66), with a volume of 18,441 shares.
Analysts Set New Price Targets
ANP has been the topic of several recent research reports. Shore Capital reaffirmed a "house stock" rating on shares of Anpario in a research report on Monday, March 31st. Canaccord Genuity Group lifted their target price on Anpario from GBX 380 ($5.01) to GBX 500 ($6.59) and gave the company a "buy" rating in a research note on Tuesday, January 14th.
Check Out Our Latest Report on Anpario
Anpario Stock Up 1.1%
The company's fifty day simple moving average is GBX 399.81 and its 200-day simple moving average is GBX 394.69. The firm has a market capitalization of £79.31 million, a PE ratio of 25.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16.
Anpario (LON:ANP - Get Free Report) last posted its quarterly earnings data on Monday, March 31st. The company reported GBX 28.40 ($0.37) earnings per share for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. On average, analysts forecast that Anpario plc will post 23.5757801 EPS for the current year.
Anpario Increases Dividend
The firm also recently declared a dividend, which will be paid on Friday, July 25th. Stockholders of record on Thursday, July 10th will be paid a dividend of GBX 8 ($0.11) per share. This is a positive change from Anpario's previous dividend of $3.25. The ex-dividend date is Thursday, July 10th. This represents a dividend yield of 2.09%. Anpario's payout ratio is presently 60.74%.
Insider Transactions at Anpario
In related news, insider Marc Wilson bought 3,778 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The shares were purchased at an average cost of GBX 398 ($5.24) per share, with a total value of £15,036.44 ($19,810.86). Insiders own 30.51% of the company's stock.
About Anpario
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Articles
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
